Lamotrigine Rash
Links shared publicly online about this topic
Lamictal (lamotrigine): Label Change - Risk of Aseptic Meningitis
fda.gov — “Warnings and Precautions section of Prescribing Information and patient Medication Guide revised to include information about the risk of aseptic meningitis.” View full resource at fda.gov
Most Recently Shared on August 14, 2010 at 12:00 pm By:
Ohio Family Practice Physician Group
FDA ALERT: increased risk of Aseptic Meningitis with Lamictal http://bit.ly/cEWljt (1 case for every 1.2 million Rx's)
FDA Alert: Lamictal (lamotrigine): Label Change - Risk of Aseptic Meningitis
drugs.com — “FDA Alert: Lamictal (lamotrigine): Label Change - Risk of Aseptic Meningitis” View full resource at drugs.com
Most Recently Shared on August 12, 2010 at 11:14 pm By:
FDA Alert - Labeling Change for Lamictal (lamotrigine) - Risk of Aseptic Meningitis - http://bit.ly/9Ku1nF
First Report of Lamotrigine-Induced Drug Rash with Eosinophilia and Systemic Symptoms Syndrome with Pancreatitis (December) -- Roquin et al., 10.1345/aph.1P350 -- The Annals of Pharmacotherapy
theannals.com — “First Report of Lamotrigine-Induced Drug Rash with Eosinophilia and Systemic Symptoms Syndrome with Pancreatitis (December) -- Roquin et al., 10.1345/aph.1P350 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on November 24, 2010 at 4:38 am By:
First Report of Lamotrigine-Induced Drug Rash with Eosinophilia and Systemic Symptoms Syndrome with Pancreatitis... http://bit.ly/gyLz51
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Ohio Family Practice
We are the premier family medicine practice in Akron and Western Summit County. Drs. Dom Dera, Sabin, & Cajigas are accepting new patients.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
Advertisement
